Page last updated: 2024-08-23

paclitaxel and batabulin

paclitaxel has been researched along with batabulin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cai, SX; Drewe, J; Guastella, J; Herich, J; Jia, S; Kasibhatla, S; Nguyen, B; Reddy, S; Tseng, B	1
Beckmann, H; Chou, TC; Frankmoelle, WP; Jaen, JC; Learned, RM; Medina, JC; Narbut, MR; Rosen, T; Santha, E; Shan, B; Stott, D; Timmermans, PB; Wu, P	1

Other Studies

2 other study(ies) available for paclitaxel and batabulin

Article	Year
Discovery of substituted N-phenyl nicotinamides as potent inducers of apoptosis using a cell- and caspase-based high throughput screening assay. Journal of medicinal chemistry, 2003, Jun-05, Volume: 46, Issue:12 Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Caspases; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Niacinamide; Structure-Activity Relationship; Tubulin; Tumor Cells, Cultured	2003
Selective, covalent modification of beta-tubulin residue Cys-239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors. Proceedings of the National Academy of Sciences of the United States of America, 1999, May-11, Volume: 96, Issue:10 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cysteine; Cytoskeleton; Drug Resistance, Multiple; Humans; Leukemia, Lymphoid; Mice; Mice, Nude; Microtubules; Molecular Structure; Neoplasm Transplantation; Paclitaxel; Protein Binding; Sulfonamides; Tubulin; Tumor Cells, Cultured; Vinblastine	1999

Article

Year

Discovery of substituted N-phenyl nicotinamides as potent inducers of apoptosis using a cell- and caspase-based high throughput screening assay.

Journal of medicinal chemistry, 2003, Jun-05, Volume: 46, Issue:12

Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Caspases; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Niacinamide; Structure-Activity Relationship; Tubulin; Tumor Cells, Cultured

2003

Selective, covalent modification of beta-tubulin residue Cys-239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors.

Proceedings of the National Academy of Sciences of the United States of America, 1999, May-11, Volume: 96, Issue:10

Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cysteine; Cytoskeleton; Drug Resistance, Multiple; Humans; Leukemia, Lymphoid; Mice; Mice, Nude; Microtubules; Molecular Structure; Neoplasm Transplantation; Paclitaxel; Protein Binding; Sulfonamides; Tubulin; Tumor Cells, Cultured; Vinblastine

1999